Abstract
Although making specific reference to pharmaceutical production the problems and principles described apply to a wide variety of industries, and may therefore be of general interest. In the spirit of technology transfer the paper is deliberately written in ‘mid-Atlantic’ English.
The author is a specialist engineer within the Project Unit of a major UK-based pharmaceutical company, which operates a broadly decentralised management structure. The views expressed are his own and do not necessarily represent those of the company.
Get full access to this article
View all access options for this article.